Evid Invest
Who owns CRSPWhat CRSP owns — n/a

Who owns CRISPR Therapeutics AG?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of CRSP from SEC Form 13F filings across 599 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-06-30 reporting period, 599 institutions disclosed 92.4M shares of CRISPR Therapeutics AG worth $4.00B; the largest disclosed holder is ARK Investment Management LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

599

13F holders

$4.00B

value, 2026 filers

92.4M

shares disclosed

0

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of CRSP's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1ARK Investment Management LLC11.3M$538.2M4.2%
2BlackRock, Inc.7.7M$365.3M0.0%
3Orbis Allan Gray Ltd6.1M$290.5M1.2%
4Capital World Investors4.7M$224.8M0.0%
5STATE STREET CORP4.0M$189.4M0.0%
6GSK PLC3.2M$153.2M25.6%
7BlackRock Inc.2.8M$150.0M0.0%
8T. Rowe Price Investment Management, Inc.3.0M$140.5M0.1%
9WADDELL & REED FINANCIAL INC1.1M$130.6M0.3%
10VANGUARD GROUP INC2.3M$119.0M0.0%
11GEODE CAPITAL MANAGEMENT, LLC2.4M$113.1M0.0%
12SR ONE CAPITAL MANAGEMENT, LP2.0M$97.0M10.6%
13Sumitomo Mitsui Trust Group, Inc.1.7M$93.8M0.1%
14FMR LLC2.0M$93.0M0.0%
15Nikko Asset Management Americas, Inc.1.9M$88.2M1.2%
16UBS Group AG1.8M$83.8M0.0%
17TWO SIGMA INVESTMENTS, LP1.5M$70.5M0.1%
18EcoR1 Capital, LLC1.4M$66.1M2.8%
19Capital International Investors1.2M$56.5M0.0%
20VANGUARD CAPITAL MANAGEMENT LLC1.1M$54.4M0.0%
21NEA Management Company, LLC1.1M$50.4M2.9%
22CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.0M$49.4M0.0%
23CREDIT SUISSE AG/719,309$49.0M0.0%
24QUADRANT CAPITAL GROUP LLC158$49.0M0.0%
25BANK OF AMERICA CORP /DE/983,072$46.8M0.0%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.